Non-Consolidated Affiliates - Equity in Earnings and Distributions of Equity Method Investees (Details) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Noncontrolling Interest [Line Items] | ||||
| Distributions from equity method investees | $ 7,801 | $ 62,988 | $ 53,830 | $ 112,646 |
| The Legacy SLP Interest | ||||
| Noncontrolling Interest [Line Items] | ||||
| Distributions from equity method investees | 6,365 | 62,385 | 12,424 | 70,722 |
| Avillion I | ||||
| Noncontrolling Interest [Line Items] | ||||
| Distributions from equity method investees | 0 | 0 | 13,396 | 13,396 |
| Avillion II | ||||
| Noncontrolling Interest [Line Items] | ||||
| Distributions from equity method investees | $ 1,436 | $ 603 | 28,010 | 28,528 |
| Avillion II | AstraZeneca | ||||
| Noncontrolling Interest [Line Items] | ||||
| Distributions from equity method investees | 10,300 | 27,400 | ||
| Milestone payment received | $ 22,000 | $ 55,000 | ||